Evidence map›Paper›PMID 37636585›Full record

ArticleACS catalysis2021

Robust, Enantioselective Construction of Challenging, Biologically Relevant Tertiary Ether Stereocenters.

Yong Guan, Tadas A Buivydas, Remy F Lalisse, Jonathan W Attard, Rameez Ali, Charlotte Stern, Christopher M Hadad, Anita E Mattson

Abstract read
In one paragraph

Article in ACS catalysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Insights into the Regioselectivity of Metal-Catalyzed Aryne Reactions.Synlett : accounts and rapid communications in synthetic organic chemistry · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Phomoxanthone A Targets ATP Synthase.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  7. Dearomatization of benzopyrylium triflates with sulfoxonium ylides.Chemical communications (Cambridge, England) · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yong GuanDepartment of Chemistry and Biochemistry, Worcester Polytechnic Institute, 60 Prescott St., Worcester, MA 01609.
Tadas A BuivydasDepartment of Chemistry and Biochemistry, Worcester Polytechnic Institute, 60 Prescott St., Worcester, MA 01609.
Remy F LalisseDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210.
Jonathan W AttardDepartment of Chemistry and Biochemistry, Worcester Polytechnic Institute, 60 Prescott St., Worcester, MA 01609.
Rameez AliDepartment of Chemistry and Biochemistry, Worcester Polytechnic Institute, 60 Prescott St., Worcester, MA 01609.
Charlotte SternIntegrated Molecular Structure Education and Research Center, Northwestern University, Evanston, IL, 60208.
Christopher M HadadDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 43210.
Anita E MattsonDepartment of Chemistry and Biochemistry, Worcester Polytechnic Institute, 60 Prescott St., Worcester, MA 01609.

Funding

Silanediol Enabled Drug DiscoveryR35GM124804 · NIGMS · WORCESTER POLYTECHNIC INSTITUTE · PI MATTSON, ANITA E · 2017 to 2021
$2.0M
NIGMS NIH HHS R35 GM124804
6 · The paper itself

Abstract

A robust, catalytic enantioselective method to construct challenging, biologically relevant, tertiary ether stereocenters has been developed. The process capitalizes on readily accessible bis(oxazoline) ligands to control the facial selectivity of the addition of copper acetylides to benzopyrylium triflates, reactive species generated in situ. Up to 99% enantiomeric excesses are achieved with a broad substrate scope. Using density functional theory (DFT) calculations, the origin of the experimentally observed enantiocontrol was attributed to additional non-covalent interactions observed in the transition state leading to the major enantiomer, such as π-stacking. The resultant substrates have direct applications in the synthesis of naturally occurring bioactive chromanones and tetrahydroxanthones.

Indexed as

AlkynylationAsymmetric CatalysisChromanoneMethodologyTertiary Ether

Identifiers

PMID37636585
PMCPMC10457089

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.